Arbutus Biopharma Tops Q3 EPS by 2c

  • Investing.com
Arbutus Biopharma Tops Q3 EPS by 2c
Credit: © Reuters.

Arbutus Biopharma (ABUS) reported Q3 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $5.95 million versus the consensus estimate of $6.64 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100